Male.rar [FAST - 2026]

Studies showed 100% sterility in mice after dosing, which was found to be fully reversible after drug discontinuation.

It is designed to be a "male pill" that targets only the necessary receptor, aimed at reducing side effects found in older, less specific studies (like those using BMS-189453). Male.rar

In July 2025, Communications Medicine published results showing the candidate was well-tolerated by male volunteers in a first-in-human study. As of January 2026, it is in active clinical development. Studies showed 100% sterility in mice after dosing,